So basically they've paintented an entire approach to the treatment of KD. Smart move. The must be confident that this protein is a key to treatment and have locked themselves into royalties if they or anybody else develops a treatment using this approach. Suddenly PromarkerD has become a when lot more valuable!
Ann: US patent for identifying drugs for abnormal kidney function, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.5¢ |
Change
-0.015(2.24%) |
Mkt cap ! $85.15M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.0¢ | $46.90K | 70.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 45287 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.48pm 22/11/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |
